Point of Care Testing in Europe: Will the Benefits Overrule the Challenges?


Published on

The European Point of Care Testing Market is driven by encouraging initiatives from European governments and the development of an increasing number of POC test data management and connectivity solutions, but the cost advantages of central laboratory testing versus near patient testing is still a hindrance to its wider adoption.

Published in: Technology, Business
1 Comment
  • Point of care testing (POCT) is a new concept in laboratory medicine that is widely used at present. It is the new advent that helps ease medical care in the present day. The knowledge on the POCT medicine is very important and necessary for the general practitioner. In this specific book, the author summarizes, presents and discusses on the concept of POCT, its importance and examples of important POCT tools.
    eBook: http://amzn.com/B005BYPGJK
    paperback: http://amzn.com/1466256958
    Are you sure you want to  Yes  No
    Your message goes here
  • Be the first to like this

No Downloads
Total views
On SlideShare
From Embeds
Number of Embeds
Embeds 0
No embeds

No notes for slide

Point of Care Testing in Europe: Will the Benefits Overrule the Challenges?

  1. 1. Point of Care Testing: Will the Benefits Overrule the Challenges? Rasika Ramachandran, Senior Research Analyst Life Sciences Healthcare - EIA 29th June 2010
  2. 2. Focus Points • Introduction and Market Overview • Applications of Point of Care Testing • Segmentation • Revenue forecasts • Key Drivers • Geographic Trends • Industry Challenges and Strategic Recommendations • Conclusion 2
  3. 3. Introduction and Market Overview Infectious Blood Gas and Cardiac Diabetes Electrolytes Disease Fertility Coagulation Haematology Market Development Market Maturity Market Decline 3
  4. 4. Applications of Point of Care Testing Hospital Applications Community Setting Setting 4
  5. 5. Market Segmentation Haematology Diabetes Fertility Cardiac Blood Gas and Electrolytes Coagulation Infectious Disease 5
  6. 6. Revenue Forecasts 3 14 2.5 12 Revenues ($ Billions) 10 2 Growth Rate (%) $1.3 Billion 8 @ 8.2 per cent 1.5 6 1 4 0.5 2 0 0 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 Year Source: Frost & Sullivan 6
  7. 7. Key Market Drivers Encouraging initiatives from European Development of an Quick turn Availability of POC Governments aids increasing number of around time tests encourages growth of the POC test data management self-monitoring POC testing market and connectivity solutions of patients Drivers Drivers Source: Frost & Sullivan 7
  8. 8. Geographic Trends Greater thrust from government agencies for Move towards POC testing and the decentralisation of lab industrial sector acting on services in UK will lead cue to lead to POC to greater uptake of POC market expansion here tests here Autonomously operating and unregulated Majority of the country healthcare system poses still found to prefer a challenge for POC traditional testing suppliers in these regions methods to near patient testing, but a shift is expected 8
  9. 9. Industry Challenges and Recommendations Challenge 1-2 Years 3-4 Years 5-7 Years Integrating Point of Care (POC) testing into High High Medium existing infrastructure proves to be a challenging task Need for routine calibration of POC instrument is a High Medium Low challenge for its uptake in the physician office laboratory Cost advantages of central laboratory testing versus High Medium Low near patient testing is still a hindrance to its wider adoption Infatuation of senior physicians with conventional High Medium Low testing methods is a challenge for POC testing market growth 9
  10. 10. Next Steps Request a strategic approach document for a Growth Partnership Service or Growth Consulting Service to support you and your team to accelerate the growth of your company. (myfrost@frost.com) +44 (0)20 7343 8383 Join us at our annual Growth, Innovation and Leadership 2011: A Frost & Sullivan Global Congress on Corporate Growth (www.gil-global.com) Register for the next Chairman’s Series on Growth: The CEO’s Perspective on Innovation: How Creativity Fosters Growth 14 July 2010 10:00 AM BST (www.frost.com/growthEU) Register for Frost & Sullivan’s Growth Opportunity Newsletter and keep abreast of innovative growth opportunities (www.frost.com/news) 10
  11. 11. Your Feedback is Important to Us What would you like to see from Frost & Sullivan? Growth Forecasts? Competitive Structure? Emerging Trends? Strategic Recommendations? Other? Please inform us by taking our survey. 11
  12. 12. Frost & Sullivan on Twitter and Facebook Find us @Frost_Sullivan on Twitter Become a fan of Frost & Sullivan on Facebook 12
  13. 13. For Additional Information Katja Feick Noel Anderson Corporate Communications European Vice President Healthcare New Business Development 0049 (0) 69 7703343 +44 (0)207 343 8389 katja.feick@frost.com noel.anderson@frost.com Dr. Fiona Rahman Rasika Ramachandran Program Manager Senior Research Analyst Clinical Diagnostics & Drug Discovery Life Sciences, Healthcare - EIA Healthcare +91-44-42044695 0207 343 8305 rasika.ramachandran@frost.com fiona.rahman@frost.com 13